"This is a new class of imaging agents for MRI." - Executive Chairman Bob Proulx discusses how MagSense® aims to bring molecular specificity to cancer detection in the latest @TheMarketBullAU Interview.
Watch full interview: https://t.co/yh4ZzCXrqG
$IBX #CancerDetection#MRI
$IBX $IBXO
The IND approval should be the last major catalyst for free air ahead. Note that 90% of all IND applications are active within 30 days. The market is missing a massive opportunity to get in low. Too much upside here for me to sell. Maybe a bit of topping up.
🤔
🎥 $IBX Imagion Biosystems Executive Chairman Bob Proulx joins TMB to discuss the lodging of its first Investigational New Drug application with the U.S. Food and Drug Administration for the MagSense® HER2 Imaging Agent.
@imagionbio
$IBX has lodged its Investigational New Drug (IND) application for the MagSense® HER2 Imaging Agent to the U.S. Food and Drug Administration (FDA).
What is the timeline process from here?
#ASX@imagionbio#biotech
$IBX has lodged its Investigational New Drug (IND) application for the MagSense® HER2 Imaging Agent to the U.S. Food and Drug Administration (FDA).
What is the timeline process from here?
#ASX@imagionbio#biotech
$IBX has lodged its Investigational New Drug (IND) application for the
MagSense® HER2 Imaging Agent to the U.S. Food & Drug Administration FDA!!!
A major milestone in the clinical development of the company’s
proprietary MagSense® platform!!
Phase 2 Clinical Trial enrollment planned to commence following FDA approval!
@imagionbio
Huge news!!! Re rate incoming?!
👏🏼
The US government just announced a $1.6B investment in USA Rare Earths (USAR)—the largest government investment in mining in American history.
Here's the reason behind it (and the multi-year investment opportunity this creates for investors): 🧵
The US government just announced a $1.6B investment in USA Rare Earths (USAR)—the largest government investment in mining in American history.
Here's the reason behind it (and the multi-year investment opportunity this creates for investors): 🧵